|
Connect. Collaborate. Contribute.™
|
|
|
with Ilya Finkelstein Jason McLellan Department of Molecular Biosciences University of Texas at Austin Online on Zoom 6:00-6:15pm Networking 6:15-7:30pm Presentation 7:30-8:00pm Q&A |
Vertical Divider
|
One year ago, the World Health Organization declared the novel coronavirus a pandemic and the US declared a national emergency. In a year, we used technology to sequence the virus, develop tests, and create vaccines and treatments in record time and scale. However, the virus has also evolved — we’re not out of the woods yet.
In this presentation, UT Austin professors Ilya Finkelstein and colleagues will share exactly where the pandemic is in terms of vaccine and therapeutics, how science and technology have helped create the treatments rapidly (and their role in it!), how to understand effectiveness and risks, what virus variants we are seeing now, and what the next steps are in using data, science, and technology in identifying and addressing SARS-CoV-2 variants and future pandemics. SARS-CoV-2 == virus COVID-19 == disease caused by the virus |
speaker
Ilya Finkelstein
Department of Molecular Biosciences University of Texas at Austin |
Dr. Ilya Finkelstein is an Associate Professor of Molecular Biosciences at the University of Texas at Austin. Prior to his position at UT-Austin, Dr. Finkelstein received a B.S. from the University of California, Berkeley, a Ph.D. in Chemistry from Stanford University, and completed postdoctoral training at Columbia University Medical Center. Dr. Finkelstein’s lab is investigating the molecular mechanisms of genome maintenance, CRISPR biology, and epigenetic inheritance. In the past year, his group redirected their efforts to studying the SARS-CoV-2 virus with the twin goals of improving next-gen vaccines and creating new therapeutic avenues to end the COVID-19 pandemic.
Lab website: https://finkelsteinlab.org/ |
Jason McLellan
Department of Molecular Biosciences University of Texas at Austin |
Jason McLellan earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr. Daniel Leahy. He then carried out postdoctoral research at the National Institutes of Health's Vaccine Research Center in the laboratory of Dr. Peter Kwong and in collaboration with Dr. Barney Graham. In the Fall of 2013, he joined the faculty at the Geisel School of Medicine at Dartmouth in the Department of Biochemistry, and in January 2018 he moved his laboratory to the University of Texas at Austin and became a member of the Department of Molecular Biosciences. His lab is interested in elucidating the molecular mechanisms of host–pathogen interactions and leveraging the resulting information for the development of vaccines and immunotherapies.
|
